Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Debt to Equity (2025)

CG Oncology filings provide 1 years of Debt to Equity readings, the most recent being $0.0 for Q4 2025.

  • On a quarterly basis, Debt to Equity changed N/A to $0.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.0, a N/A change, with the full-year FY2025 number at $0.0, changed N/A from a year prior.
  • Debt to Equity hit $0.0 in Q4 2025 for CG Oncology, down from $0.0 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.0 in Q3 2025 to a low of $0.0 in Q4 2025.